How to File a Patent in the European Union: A Practical Guide for Foreign Businesses

The first thing to get straight, because almost every foreign business gets it wrong, is that there is no single EU patent granted by an EU institution. The EUIPO handles EU trade marks and designs, not patents. Patents in Europe run through a different system built on the European Patent Convention, which is not EU law and whose membership is broader than the EU. So when someone asks how to patent an invention in the European Union, the honest answer is that you choose between three routes that overlap but are not the same: a European patent granted by the European Patent Office, a Unitary Patent layered on top of that grant, or separate national patents. This guide walks through how each works, where examination and opposition sit, and the practical traps that catch foreign applicants. It is general information, not legal advice. For anything fact-specific, including drafting claims or choosing between routes, consult a vetted local firm.

The three routes, and why the distinction matters

A European patent is granted centrally by the European Patent Office (EPO) under the European Patent Convention (EPC). One application, one examination, one grant. What you get at grant, historically, is not a single right but a bundle: to take effect in any given country you generally have to validate the granted patent in that country, which can involve national steps and, in some states, translations. The EPC covers more states than the EU, including non-EU members, so a European patent can reach markets the EU does not. The current list of contracting states is published by the EPO and changes over time, so confirm coverage there.

The Unitary Patent sits on top of an EPO grant. Since it became available (the system opened for use during 2023), an applicant can request unitary effect after grant, producing a single right with uniform effect across the participating EU member states, enforced and revoked centrally through the Unified Patent Court. The point foreign businesses most often overstate is coverage: the Unitary Patent covers only the EU states participating in the scheme, not all EU members and certainly not the full EPC membership. The set of participating states can grow as more member states join, so check the current position rather than assuming it is fixed. For any state outside the unitary system, you still validate the European patent nationally in the ordinary way. In practice many applicants combine a Unitary Patent for participating states with national validations elsewhere.

National patents are the third route. Each European country has its own patent office, and you can file directly there for protection limited to that country. This can make sense for a single key market, but it does not scale well across Europe, which is the whole reason the EPO route exists.

Who can apply

Anyone can apply for a European patent. There is no nationality or residence requirement, and you do not need a business presence in Europe or prior use there, because patents protect inventions rather than market activity. A foreign business can be the named applicant directly.

The practical constraint is representation. An applicant without a residence or principal place of business in an EPC contracting state generally must act through a professional representative, typically a European patent attorney on the EPO list, for substantive proceedings. This tends to be a structural feature of the system rather than an optional convenience, so factor representation into your timeline and budget from the outset, and confirm the current requirement for your circumstances. The same broad pattern applies at national offices, which usually require a local address for service or a local agent for foreign applicants.

Searching and clearance before you file

Patents are examined for novelty and inventive step against everything already public anywhere in the world, so a prior-art search before filing is not optional housekeeping; it shapes whether the application is worth filing at all and how to draft the claims. The EPO publishes patent documentation through Espacenet, and the EPO itself produces a search report during prosecution, but a professional search before filing gives you a realistic picture of the landscape and lets you scope the claims sensibly.

Two points catch foreign businesses out. First, your own prior disclosure can destroy novelty. Europe takes a strict approach to absolute novelty, with only narrow exceptions, so publishing, demonstrating, or selling the invention before you file can sink a European application even though some other jurisdictions allow a grace period. File before you disclose. Second, a patentability search is not a freedom-to-operate search. Being able to patent your invention does not mean you are free to sell it without infringing someone else's patent; those are different questions, and a serious product launch usually needs both. Where the search result is ambiguous, that is exactly the nuance to put in front of a vetted local firm.

The application and examination process

A European patent application includes a request for grant, a description of the invention, one or more claims defining what you seek to protect, any drawings, and an abstract. If you are claiming priority from an earlier first filing under the Paris Convention, you generally must do so within a set period after that first filing, commonly understood to be around a year, but confirm the current deadline with the EPO rather than relying on a figure here, because missing it can forfeit the priority date.

After filing, prosecution at the EPO broadly runs through these stages.

Two timing points matter. Substantive examination generally has to be actively requested within a deadline, and the request carries a fee; let it lapse and the application is deemed withdrawn. After grant, the deadlines to validate in national states and to request unitary effect are short and unforgiving. Both are time-sensitive, so treat any specific figure as something to confirm with the EPO or your representative rather than to rely on from this article.

Opposition

The EPO runs a centralised, post-grant opposition procedure. For a defined period after the grant is published, any third party can file an opposition asking the EPO to revoke or amend the patent, typically on grounds such as lack of novelty or inventive step, insufficient disclosure, or added subject matter. This is genuinely useful for foreign applicants to understand on both sides: it is a relatively cost-effective way to attack a competitor's European patent centrally, and it is a risk your own patent carries for a window after grant.

If no opposition is filed, or an opposition fails, the patent stands. If it succeeds, the patent can be revoked or maintained in amended form, with effect across the validated states. Separately, a granted patent can later be challenged through national revocation actions, or, for patents within its competence, through the Unified Patent Court, which can revoke a patent centrally. Because the deadlines and grounds are specific and time-limited, monitoring and acting quickly matter, and a local firm can run watch services and handle filings within the deadlines. Confirm the current opposition window with the EPO before relying on it.

Roughly how long it takes

Timelines vary widely and depend heavily on the technical field, the number of office actions, and whether you accelerate prosecution, so treat any single figure with caution. As an indicative range, prosecution from filing to grant at the EPO commonly runs over a period of several years rather than months, with the search, examination requests, and rounds of office actions occupying most of that. Straightforward cases that meet few objections move faster; contested or complex ones take considerably longer. Accelerated examination options exist for applicants who need a quicker outcome.

Do not plan around an optimistic best case. Build in margin, file before any public disclosure, and confirm current processing expectations on the EPO's official channels or with your representative rather than relying on a fixed number that may be out of date.

Maintenance and renewal

European patents and applications attract renewal fees to stay in force, and the structure differs across the routes, which surprises foreign businesses budgeting for a single line item. During prosecution, renewal fees are generally payable to the EPO. Once a European patent is validated nationally, renewal fees for each validated country are then paid to that national office, in that country's currency, on that country's schedule, so a patent validated in several states means several separate renewal streams. A Unitary Patent, by contrast, carries a single renewal fee paid centrally for the participating states, which is part of its appeal.

Patent terms in Europe are generally counted from the filing date and run for a fixed maximum period set by the governing law, subject to paying renewals, with supplementary protection certificates available in limited fields such as pharmaceuticals to extend protection in specific circumstances. Because the exact term, fee schedules, deadlines, and any grace periods are version-specific and differ by office, do not rely on figures here; confirm the current position with the EPO and the relevant national offices. Diarise renewals well ahead and confirm the current windows and fees with the EPO, the relevant national offices, or through your representative. Missing a renewal risks lapse of the patent, after which the protection is gone.

The international route

Most foreign businesses filing across multiple regions reach Europe through the Patent Cooperation Treaty (PCT). A single international application under the PCT preserves your filing date across the many member states and buys time, through an international phase, before you have to commit to and pay for protection in specific regions. You then enter the regional or national phase, and for Europe that typically means entering the European phase before the EPO, which proceeds much like a direct European application from there.

The trade-off is familiar. A direct European or national filing is more direct when Europe is your main or only target. The PCT route is usually more economical and strategically flexible when you are filing in several regions at once, because it defers the larger costs and the choice of countries while keeping your options open. The national-phase deadlines under the PCT are strict and forfeiting them is permanent, so they are a classic trap; confirm the applicable deadline before relying on it. For the wider mechanics of the international system, see our overview of the PCT route, and for the European patent landscape see the European patents pillar. For comparison with other markets, see how filing works in China, the United States, India, and Türkiye.

Practical risks a foreign business should know

A handful of risks recur often enough to flag directly. First, the conceptual one: there is no single EU patent, so any plan that assumes one right covering all of Europe from one EU office is built on a false premise; map your target markets to the EPC, the Unitary Patent's participating states, and national offices deliberately. Second, premature disclosure: Europe's strict approach to novelty means publishing, pitching, or selling before you file can destroy patentability, so file first. Third, the validation and renewal sprawl: a European patent validated across several states becomes several national renewal obligations in several currencies on several calendars, and a missed payment anywhere lets that country's protection lapse.

Fourth, the post-grant exposure: the opposition window and, for relevant patents, central revocation through the Unified Patent Court mean a granted patent is not unassailable, so monitor and keep your prosecution clean. Fifth, the representation and language requirements: substantive proceedings for foreign applicants generally run through a qualified European or local representative, and quality varies. None of these is exotic, but each has caught out well-resourced businesses. Because the consequences are jurisdiction-specific and often turn on facts, the sensible course before filing in Europe is to consult a vetted local firm to pressure-test your route choice, your disclosure timing, and your claims.

This article is general information and not legal advice. Official requirements, fees, and processing times are set by the EPO and national offices and change over time; always confirm current details on official channels or through qualified local counsel.